Skip to content
Drug recall · FDA · Published December 4, 2023

SUN PHARMACEUTICAL INDUSTRIES INC recalls Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical recalls 100-count Liothyronine Sodium Tablets (5 mcg) due to failed impurities and degradation specifications. Rx-only medication distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.

🇺🇸 FDA recall #D-0150-2024DrugSun Pharmaceutical ›
Take action

Contact the company & request your remedy

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way, N/A · Princeton, NJ 08540-6620
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceutical is recalling 100-count Liothyronine Sodium Tablets (5 mcg) because they failed impurities and degradation specifications. This medication is prescription-only and may pose health risks if the tablets contain harmful substances. Read more at govinfonow.com/recall/32933-sun-pharmaceutical-liothyronine-tablets-recall-failed-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32933-sun-pharmaceutical-liothyronine-tablets-recall-failed-impurities-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0150-2024

Cite this page

“Sun Pharmaceutical Liothyronine Tablets Recall: Failed Impurities Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32933-sun-pharmaceutical-liothyronine-tablets-recall-failed-impurities-risk. Based on FDA recall #D-0150-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0150-2024%22&limit=1).

Why it’s dangerous

The tablets failed impurities and degradation specifications, meaning they may contain harmful substances that could affect thyroid function. This is a medication that requires precise dosing for health management.

Who’s affected

Prescription patients who have the specific lot numbers listed in the recall notice. Those with thyroid hormone replacement medication are most at risk.

How to tell if you have this one

Check for the product name 'Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle' with the lot numbers DND0059A through DND0184A as listed in the recall notice.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the lot numbers on the packaging: DND0059A through DND0184A for the recalled tablets.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall states the tablets failed impurities and degradation specifications, but the official notice does not specify if the medication is safe to use.

How can I tell if I have the recalled product?

Check for the lot numbers DND0059A through DND0184A on the packaging of Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottles.

What should I do if I have the recalled product?

The recall notice does not specify a remedy, so the official notice does not state what action to take.

Take action

Contact Sun Pharmaceutical

We’ve drafted a message you can send Sun Pharmaceutical to request your refund or repair — edit it as you like.

Subject: Recall D-0150-2024 — Sun Pharmaceutical Sun Pharmaceutical

Hello,

I own a Sun Pharmaceutical that is covered by recall D-0150-2024 from Sun Pharmaceutical.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0150-2024 (December 4, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0150-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA